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Abstract
The term proteoform is used to denote all the molecular forms in which the pro-
tein product of a single gene can be found. The most frequent processes that lead to 
transcript modification and the biological implications of these changes observed in 
the final protein product will be discussed. Proteoforms arising from genetic varia-
tions, alternatively spliced RNA transcripts and post-translational modifications 
will be commented. This chapter will present an evolution of the techniques used to 
identify the proteoforms and the importance of this identification for understand-
ing of biological processes. This chapter highlights the fundamental concepts in the 
field of top-down mass spectrometry (TDMS), and provides numerous examples 
for the use of knowledge obtained from the identification of proteoforms. The 
identification of mutant proteins is one of the emerging areas of proteogenomics 
and has the potential to recognize novel disease biomarkers and may point to useful 
targets for identification of therapeutic approaches.
Keywords: post-translational modifications, top-down, mass spectrometry, 
proteomic experiments, clinical application of proteoform
1. Introduction
A surprise from the human genome project was the identification of 23,000 
genes, far fewer than the estimated 100,000. Some events create distinct pro-
teins that articulate various biological processes from cell signaling to genetic 
regulation. Thus, a single gene by allelic variations, alternative splicing and other 
pre-translational mechanisms, such as post-translational modifications (PTMs), 
conformational dynamics and functioning, may generate specific molecular 
forms of proteins, named “proteoforms,” with different structures and differ-
ent functions. Proteoforms or protein species as previously defined [1] could be 
identified by proteomics experiments, which include quantification of protein 
abundance, investigation of changes in protein expression, characterization 
of post-translational modifications (PTMs), identification of protein-protein 
interactions, a measure of isoform expression, turnover rate and subcellular 
localization [2]. Frequent modifications that produce proteoforms are presented 
in Figure 1.
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2. Proteomic experiments
The advance of genomics enabled the sequencing of the genes of an organism, 
but this does not inform which proteins may be present or how they are modified in 
specific situations. The proteomics analyses begin with the combination of multi-
dimensional separation included the chromatographic and gel electrophoresis tech-
niques and the ability of mass spectrometry to identify and to precisely quantify the 
proteins. Many different technologies have been and are still being developed to get 
the information contained in proteoforms. The high-precision mass spectrometric 
measurements as the tandem mass spectrometry (MS/MS or MS2 (peptide mass 
fingerprinting)) can provide structural information on molecular ions that can be 
isolated and fragmented [3, 4]. Mass spectrometry-based proteomics can be carried 
out in a bottom-up or top-down approach.
2.1 Bottom-up proteomics
The bottom-up proteomics also termed “shotgun proteomics,” when the bottom-
up analysis is performed on a mixture of proteins, has traditionally been used. In 
this approach, proteins that could be a simple or complex mixture are digested by 
chemical or enzymatic digestion to generate peptides that are analyzed by way of 
MS2. It is generally applied to identify and characterize many peptides in a mixture 
and deduce the identity of the protein to exist in the sample [5, 6]. In strategy 
bottom-up, the peptides mixture resulting of the digestion is fractionated and sub-
jected to multidimensional liquid chromatography, which consists of prefractionat-
ing of peptides first according to their net charge using strong cation exchange 
chromatography and second, according to their hydrophobicity by reversed phase 
liquid chromatography (RP-LC) coupled online with a mass spectrometer [7]. The 
peptides fragmented within the mass spectrometer will provide product-ion mass 
spectra which are compared with in silico-generated MS/MS of the same mass 
encoded in a protein database. Proteins present in the sample are then inferred from 
the identified peptides [8].
Figure 1. 
Types of proteoforms: RNA splicing and mutations.
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This approach brings up several disadvantages: the protein inference process 
can be complicated because proteins often contain homologous sequence regions 
and the peptides cannot be either uniquely assigned to a single protein, the same 
peptide might have originated from multiple protein isoforms and/or from distinct 
functional pools of the same protein [2, 9]. The digestion of proteins can cause loss 
sequence variations or information regarding the original amino acid sequence 
and loss information relationship between the amino acid sequence and the PTMs 
belonging to specific proteoforms; thus, it is not capable of identifying proteoforms 
[6, 10]. Introducing the intact protein into the mass spectrometer eliminates these 
problems, the strategy used by the top-down mass spectrometry.
2.2 Top-down proteomics
Differently, of the bottom-up proteomics, the “top-down” approach involves 
direct separation and MS analysis of intact proteins, without previous proteolytic 
digestion. By this method, proteoforms can be characterized since the relation-
ship between the amino acid sequence and the PTMs is preserved, and thus, such 
characterization provides a proteoform-specific understanding of biological 
phenomena [10]. In top-down proteomic, a specific proteoform of interest can be 
directly isolated and, subsequently, fragmented in the mass spectrometer by MS/
MS strategies to map both amino acid variations to obtain information on protein 
masses [11]. The masses describe the complete amino acid sequence, including all 
post-translational modifications, structures, for successful identification [12, 13].
In this proteomic analysis, proteoforms are identified using precursor mass 
and fragmentation data. A precursor mass spectrum (MS1) of intact proteins is 
recorded; the most intense peaks are selected for fragmentation; and mass spectra 
(MS2) of the resulting fragment ions are acquired. On this account, both its intact 
and fragment ions’ masses are measured, and the precursor masses and their 
isotopic distributions present a complex but detailed set of information. Upon 
fragmentation, terminal fragments represent potential cleavage site(s) or trun-
cated proteoforms, while (internal) fragment ions can indicate modifications and, 
depending on the achieved sequence coverage, possible location. This approach 
routinely allows for 100% sequence coverage and full characterization of proteo-
forms [6, 13]. Top-down mass spectrometry has become the approach handy for 
the analysis of single proteins or simple mixtures of significant biological interest. 
Complexes proteomic samples require that they are fractionated before to introduc-
tion to the mass spectrometer. Many separation strategies can be applied before 
mass spectrometer only the last step, usually, the RPC coupled to mass spectrom-
etry [6, 14].
Proteomic top-down may be denaturing or native. Denaturing top-down 
proteomics (dTDP), the procedure denaturing provides a powerful technique for 
characterizing individual proteins <30 kDa. In these studies, the proteins are dena-
tured prior to their introduction into the mass spectrometer [15]. In this approach, 
protein interactions and quaternary conformations are disturbed by means of 
substance such as organic solvents, reducing agents, strong detergents, non-phys-
iological pH, and/or physical method as heat and pressure [16]. TDP is the most 
disseminated and the scoring system used for identification and characterization of 
proteoforms. It has naturally been developed and tested using datasets derived from 
denatured top-down mass spectrometry experiments [17].
Native top-down proteomics (nTDP) has been used to characterize intact, 
non-covalently bound protein complexes biologically relevant as non-covalent 
protein-protein and protein-ligand interactions, providing stoichiometry and 
structural information since tertiary and quaternary structures of proteins are 
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maintained [6, 18]. The technique utilizes non-denaturing and non-reducing-
buffer conditions during the electrospray ionization process which helps preserve 
the primary and quaternary compositions of proteins and their complexes for MS 
[19, 20]. In native proteoform approach, analytical platforms for high-resolution 
and liquid-phase separation of protein complexes are required prior to native mass 
spectrometry (MS) and MS/MS [21]. During, Escherichia coli proteome analysis, 
144 proteins, 672 proteoforms, and 23 protein complexes were identified, cou-
pling the size-exclusion chromatography and capillary zone electrophoresis-MS/
MS [21]. Other separation techniques have been combined; coupled off-line ion-
exchange chromatography or gel-eluted liquid fraction entrapment electrophoresis 
(GELFrEE), which demonstrates the compatibility of native GELFrEE with native 
and tandem mass spectrometry [21, 22]. An illustrative scheme of the elucidation of 
the proteoform structures by the bottom-up and top-down techniques is presented 
in Figure 2.
3. Separation techniques applied to proteoforms
The number of proteoform species in a proteome could be vast. Separating pro-
teoforms is essential because many high-resolution mass spectrometers due to limited 
charge capacity have a finite ability to detect proteoforms. High-resolution separation 
techniques for complex protein samples are significant challenges of top-down pro-
teomics. To optimize proteome coverage, separation, and multidimensional combina-
tions, strategies are employed, thus, to reduce the complexity of the samples [23]. The 
strategies of separation of proteoforms are based on your intrinsic characteristics and 
physicochemical properties, such as mass/size, isoelectric point and hydrophobic-
ity. Advances in instrumentation, chromatographic and electrophoretic separation 
Figure 2. 
Comparative scheme between top-down and bottom-up proteomics, showing the best indication of top-down 
use for the identification of proteoforms in complex protein mixtures.
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strategies have been developed to separate intact proteins [20] since polyacrylamide 
two-dimensional gel electrophoresis (2D-PAGE) [24, 25] to the development of gel-
eluted liquid fraction entrapment electrophoresis (GELFrEE), capillary zone electro-
phoresis (CZE) [20, 24–26]. Specific columns are also developed for classical methods 
of separation such as hydrophobic interaction chromatography (HIC), hydrophilic 
interaction chromatography (HILIC), reversed phase liquid chromatography 
(RPLC), chromatographic ion exchange (IEX) and size exclusion (SEC) [21–23, 27]. 
Some separations can be on-line with a mass spectrometer as separations chromatog-
raphy and capillary electrophoresis, but many others can be applied off-line only [26]. 
Off-line separations approach, independent of the mass spectrometer, is flexible and 
diversified, allowing the use of diverse techniques of separations, although it is more 
laborious considering the time of collection and treatment of the fractions. Off-line 
separations system consists of three steps: separation of the sample compounds in the 
first dimension; a collection of different fractions for subsequent sample treatment; 
and injection of each of the fractions in the second dimension to be subject to analysis 
[20]. On-line separations, coupled directly to mass spectrometry, allow increased 
throughput and substantially reduce sample handling, but have limitations to sample 
loading, data acquisition and separation conditions [6, 26]. Many techniques of 
fractionation and separation can be combined to reduce the complexity of samples, 
and an off-line approach coupled with an on-line separation may be necessary since 
most proteomic samples have such complexity that they need multiple separation 
steps combined in multidimensional separations [27].
3.1 Sample preparation for top-down proteomics
The preparation of samples is one of the most critical steps for top-down 
proteomics. Conventional buffers for protein extracting as the detergents sodium 
dodecyl sulfate (SDS) and Triton X-100  are not compatible with MS [12]. Many 
methods for lysing samples use saline buffers, reducing agents, and protease and 
phosphatase inhibitors to extract proteoform avoiding alteration or degradation. 
Post extraction is needed to remove or replace nonvolatile salts that suppress MS 
signal by forming adducts to protein ions and increase the chemical noise [26]. The 
most strategies of proteins solubility for proteoforms studies, despite preserving 
many covalent interactions, denature proteins prior to MS and destroy important 
interactions such as protein-protein. In general, these interactions are essential for 
many different cellular processes [28]. In procedures for top-down native, the pH 
must be kept neutral and isolating, and fractionating of proteoforms complexes 
cannot contain denaturing agents such as strong detergents, reducing agents and 
organic solvents [29]. For these proteins to remain in their native states, a buffer is 
generally used for maintaining physiological ionic strength and neutral pH of the 
sample. To minimize noise associated with common buffer and others numerous 
interfering components, top-down sample cleanup methods should be applied; 
for example, protein precipitation and molecular weight cut-off ultrafiltration. 
Donnelly’s et al. guide is one of the best-practice protocols for MS of intact proteins 
from mixtures of varying complexity [30].
3.2 Two-dimensional gel electrophoresis (2DGE)
2D-PAGE is an electrophoretic separation technique still used to separate intact 
proteins; the protein separation in 2D-PAGE is based on the isoelectric point and 
molecular weight (MW) of the proteins. This technique was introduced by O’Farrell 
[31], and it separates cellular proteins under denaturing conditions and enables the 
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resolution of hundreds of proteins. In the first dimension, the separation is based 
on the proteoforms net electric charge (isoelectric point) of each protein and in the 
second dimension, in the presence of sodium dodecyl sulfate (SDS), proteins will 
be separated according to their molecular mass [31, 32]. The denaturing conditions 
introduced to O’Farrell [31] for first dimension comprise conducting a sample 
preparation, using high concentration molar of urea (9 mol/L), nonionic detergent 
(Nonidet NP-40) and a thiol reagent (2-mercaptoethanol), obtaining in this way an 
efficient separation of the proteins contained in the complex sample [33]. The use, 
in the first dimension, of tube gels and ampholytes to establish the pH gradient was 
replaced by the introduction of immobilized pH gradients (IPG strips). A significant 
advance on 2D-PAGE occurred with the development of the IPGs by [34] available 
in various ranges of pH and size. The IPG in polyacrylamide gels allows an efficient 
and reproducible separation of the proteins. In IPGs, the carrier ampholytes are 
attached to acrylamide molecules and cast into the gels to form a fixed pH gradient 
and covalently bound to a film backing. In this case, the buffering groups are grafted 
to the acrylamide gel matrix, the gradients cannot drift, and the gel slabs can be cut 
to narrow, usually 3 mm wide. Using IPG strips, the first-dimension separations 
are more reproducible and have high throughput and high resolution. The IPGs are 
much easier to handle, and there is the convenience provided by commercial produc-
tion of IPG strips made [33, 35, 36].
3.3 Differential in gel electrophoresis (DIGE)
Conventional 2D gels were revolutionized with the introduction of the differen-
tial gel electrophoresis (DIGE), which allow the accurate and reproducible quan-
tification of multiple samples by the relative intensity of fluorescent-dyed protein 
spots that are quantified within the same gel. Difference gel electrophoresis enables 
the accurate quantification of changes in the proteome, including proteoforms 
[37]. It is a strategy that has been developed for the quantitative analysis of intact 
proteins, and provides important information about changes caused by events such 
as truncation, degradation, genetic code variation, alternative splicing, post-trans-
lational processing and PTMs [37, 38]. The proteins in each sample are covalently 
tagged with different color fluorescent dyes, known as CyDye DIGE fluorescent. 
Fluorescent labeling of proteins is performed prior to 2D-DIGE, and then minimal 
labeling is often performed, such that <5% of proteins are labeled, thus reducing 
interference with downstream mass spectrometric analysis [39]. 2D DIGE involves 
the use of a reference sample, known as an internal standard, which comprises equal 
amounts of all biological samples in the experiment [39]. The major advantages of 
DIGE are the high sensitivity and linearity of the dyes utilized, its straightforward 
protocol, as well as its significant reduction of inter-gel variability, which increase 
the possibility to unambiguously identify biological variability and reduce bias from 
experimental variation [39, 40].
3.4 Gel-eluted liquid fraction entrapment electrophoresis (GELFrEE)
GELFrEE is a type of approach based on protein array developed to overcome 
the difficulties related to gel-based. It is one robust strategy that promotes size-
based separation of proteoforms (applied to proteins 10–250 kDa) in the liquid 
phase with high resolution. GELFrEE is a electrophoresis to accommodate broad 
mass range separation of proteins, and the separation can be performed under 
denaturing or also been adapted for native-state size separations, where the tertiary 
and quaternary structures of the proteins are maintained [16, 22, 41]. In GELFrEE, 
the gel column is used to achieve electrophoretic separation of proteins, analogous 
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to SDS-PAGE. The proteins are loaded onto the top of a tube containing poly-
acrylamide gel; for separation to occur, a voltage is applied between the anode and 
cathode reservoirs which are then eluted into the liquid-phase for manual collec-
tion, securing that higher molecular weight proteins are not continually diluted and 
dispersed across many fractions [6]. The detergents incompatible with MS can be 
removed using organic solvent precipitation before online LC-MS. Spin columns 
are coupled in-line matrix removal platform to enable the direct analysis of samples 
containing SDS and salts detergents used in native mode [6, 42, 43]. This technique 
has the advantage of separating proteoforms over a wide mass range in short time 
and at high load, but there is the disadvantage of loss of resolution in the detergent 
removal stage; an acid labile surfactant may be an alternative to SDS [44]. Many 
combinations on-line or off-line GELFrEE with other fractionation techniques 
have been applied for optimal workflows for large-scale intact protein analysis. The 
fractions obtained from the electrophoretic step GELFrEE (for molecular-weight-
based fractionation) are submitted to a second separation dimension. Li et al. [18] 
identified 30 proteins in the mass range of 30–80 kDa from Pseudomonas aerugi-
nosa, fractionated by GELFrEE, analyzed by CZE-ESI-MS platform. However, the 
workflow of additional separation procedure most commonly performed is using a 
GELFrEE-LC-MS/MS [45–47].
3.5 Capillary zone electrophoresis
CZE has been the most common CE mode applied to the mass spectrometry of 
intact proteins. It is a method of proteoforms separation based on electrophoretic 
mobility differences that do not require a stationary phase [20, 48]. This approach 
provides fast and efficient separations. The sample is injected into an electroosmotic 
flow generated by the potential difference between two ends of a capillary filled 
with an aqueous solution, and the molecules are separated by the electrophoretic 
mobility difference. Capillary zone electrophoresis (CZE) offers alternative and 
high-capacity separation of proteoforms based on their sizes and charges, and are 
useful for the separation of high-mass proteoforms by not having stationary phase 
[49, 50]. CZE has been an alternative to RPLC; for example, CZE-MS interfaces 
have better sensitivity to detection, and it can produce more protein identifications 
from complex proteome samples than typical RPLC-MS [51]. The combination of 
methods CZE has led to efficient separation and highly sensitive detection of intact 
proteoforms with the benefit of low sample amount needed, inclusive for native 
proteomics, but some challenges still need to be overcome [20, 52].
3.6 Liquid chromatography systems
Liquid chromatography is the main proteomic approach used for protein 
separation in the mono- or multidimensional modes, which is ideally suited for 
proteomics because it can be interfaced with MS. The basic principle of chro-
matographic separation is the different affinity of analytes for the stationary and 
mobile phase. The LC-based separation methods have the advantage that they can 
be coupled directly with MS [53, 54]. Various orthogonal separation techniques 
using different stationary phase with different types interactions selectivity, two-
dimensional LC separation (2D LC), and multidimensional LC separation (MDLC) 
are often combined to improve intact protein separation and proteoform coverage 
and to increase the dynamic range of detection. Multiple orthogonal separations 
include reversed phase (RP), ion exchange (IEX), size-exclusion (SEC), hydrophilic 
interaction liquid chromatography (HILIC) and hydrophobic interaction liquid 
chromatography (HIC).
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3.6.1 Reversed phase liquid chromatography separation (RPLC)
The separation of the proteoforms in RPLC is based on their hydrophobic-
ity using a non-polar stationary phase and a polar mobile phase; the analytes are 
subsequently eluted using increasing concentrations of organic solvents. The 
RPLC approach is widely used for complex intact protein sample separation and 
fractionation, and when coupled online with MS, it is the most prevalent approach 
for studying complex intact protein samples in top-down proteomics [13, 55]. 
Efficient separations to improve peak capacity have been achieved with the use of 
longer columns’ smaller particle sizes in ultra-high pressure LC systems such as 
long column ultrahigh-pressure liquid chromatography (UPLC). Particle gener-
ally, either silica-bonded or polymeric-bonded octadecyl (C18), octyl (C8), or 
other shorter alkyl chains stationary phases are used such as C4 and C5 for intact 
protein separation [56–58]. The separation of the proteoforms in RPLC is based on 
their hydrophobicity using a non-polar stationary phase and a polar mobile phase; 
the analytes are subsequently eluted using increasing concentrations of organic 
solvents. Effective separations to improve peak capacity have been achieved with 
the use of longer columns smaller particle sizes in ultra-high pressure LC systems 
such as long column ultrahigh-pressure liquid chromatography (UPLC). Particle 
generally, either silica-bonded or polymeric-bonded octadecyl (C18), octyl (C8), 
or other shorter alkyl chains stationary phases are used such as C4 and C5 for intact 
protein separation [55–57]. Due to extreme complexities, limited sample loading 
amounts, and large dynamic ranges of intact protein samples, RPLC alone may 
not provide sufficient proteome coverage for top-down proteomics. One common 
way to increase peak capacity in RPLC and increase the proteome coverage is to 
include 2D RPLC or multiple orthogonal separation steps during analysis. Some 
high- resolution techniques combined with RPLC, for separation of proteins and 
proteoforms, for example, IEX-HILC-RPC/MS, high-pH and low-pH RPLC 2D  
(2D pH-RPLC-RPLC), are used for mass spectrometry compatible [58, 59].
3.6.2 Ion exchange chromatography (IEX)
Ion-exchange chromatography is a LC technique for proteins separation for 
top-down proteomics based on differences in charge of the analyte. IEX can be 
applied in cation- and anion-exchange modes. Increasing the ionic strength of 
the mobile phase is used to elute analytes from the charged stationary phase. 
The efficiency in the separation of proteins in IEX is related to conditions to salt 
concentrations and pH elution process applications that can be well versatile. 
This approach is often employed to carry out the first dimension followed by RP 
chromatography in the second dimension to 2DLC, or 3DLC strategy using, for 
example, IEX-HILIC-RPC/MS.
3.6.3 Size-exclusion chromatography (SEC)
Size-exclusion chromatography is part of the intact protein analysis workflow. 
The fractionation occurs in the difference in the accessibility of proteins to the 
intraparticle pore volume of the resin, in the non-adsorptive mode of solute inter-
actions with the stationary-phase surface. The proteins migrate through a porous 
polymeric column and are separated by their hydrodynamic volume, with more 
abundant proteins eluting before smaller ones due to their lower accessibility to 
the interior of the packing materials. The selectivity is provided by the column, 
defined by the size of the intraparticle pore diameter; thus, the efficiency in the 
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SEC separation is mainly governed by the particle diameter [60, 61]. SEC has the 
advantage that can be realized in several types of solutions; however, it is not a high-
resolution separation method, in addition to promoting the dilution of the sample. 
To increase the performance of SEC, different aspects with respect to column 
technology and instrumentation have been addressed. Huang et al. [62] developed 
a simple and efficient method SEC-based separation of proteins using RP columns 
(RP-based SEC performed). They have applied high concentrations of acetonitrile 
with trifluoroacetic acid as an acid modifier which prevented interactions between 
proteins and the stationary phase and allowed the RP column to act as an SEC 
column to separate proteins based on their molecular weight. This innovation 
showed that the RP-based SEC performed better than conventional SEC. Cai et al. 
[63] innovated the SEC-based separation. They developed a serial size exclusion 
chromatography (sSEC) strategy to enable high-resolution size-based fractionation 
of intact proteins. They combined SEC with different pore sizes in series and an 
increase in sufficient separation length, providing an extension of fractionation 
range and higher-resolution separation of proteins pool. This strategy of sSEC 
coupled to RPLC quadrupole-time-of-flight mass spectrometry provided improved 
proteome coverage [63].
3.6.4 Hydrophobic interaction chromatography (HIC)
HIC is a technique that separates proteins based on hydrophobicity with high 
resolution for the separation of intact proteins, main native conditions, and is 
an alternative MS-compatible LC if appropriate salt is used in the mobile phase 
[14, 59]. In this approach, protein’s tertiary structure binds to a hydrophobic surface 
material in the presence of salt and then elutes in order of increasing surface hydro-
phobicity. The stationary phases used for HIC generally feature low density and 
moderate hydrophobic ligands, and resins that are less hydrophobic as compared to 
their counterparts used in RPLC, being the most.
3.6.5 Hydrophilic interaction chromatography (HILIC)
Hydrophilic interaction chromatography is a technique successfully applied 
to the separation of proteins and proteoforms. HILIC has the ability to retain and 
resolve highly polar compounds, based on a complex retention mechanism, involv-
ing hydrophilic partitioning and polar interactions; in other words, the analytes 
are eluted based on their hydrophilicity [64, 65]. In HILIC, the stationary phase is 
polar and often consists of a silica support that can be unmodified or modified with 
a polar surface chemistry, such as zwitterionic sulfoalkylbetaine, amide, diol, and 
aminopropyl; and the mobile phase consists of water and 60–95% of an aprotic, 
miscible organic solvent, usually acetonitrile (ACN) or acetone, with at least 3% 
of water. An organic solvent is used in loading HILIC columns to drive hydrophilic 
portions of proteins to interact with a hydrophilic stationary phase. Elution using a 
gradient from an organic solvent to an aqueous buffer allows desorption and elution 
of proteins from the column [66–68]. HILIC is MS-compatible LC technique for 
protein analysis. Therefore, coupling HILIC techniques in online or off-line two-
dimensional LC workflows has increased the efficiency on the LC-MS analysis of 
complex protein samples, HILIC to be complementary and orthogonal to RPLC 
[65, 69]. Gargano et al. [70] implemented a capillary HILIC-MS method that can be 
used as a high-resolution approach to separate complex mixtures of proteins using 
wide mobile-phase gradients. Salt-free pH-gradient IEX-HILIC was used as the 
second dimension for separating differentially acetylated/methylated intact protein 
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isoforms in histone family and combined this separation with RPLC online in the 
first dimension to better separation and characterization of intact histones [71].
4. Mass spectrometry
Proteomic experiments, MS based on comprehensive and total characteriza-
tion of proteoform from a biological system, besides efficient separation, employ a 
combination of sensitive detection and accuracy of intact proteins. The technology 
for identification by MS to top-down proteomics has gained impulse. The accuracy 
of mass spectrometric characterization of polypeptides involves improvement on 
ionization, fragmentation and detection conditions. Tandem MS can confirm the 
protein identification based on the daughter ions and characteristics of the obtained 
peptide map and primary structure, which thereafter provide exact localization of 
post-translational or other modification sites. Data-independent acquisition (DIA) 
methods have been alternatively used to analyze proteoforms particularly suited 
to the study of PTMs [72]. DIA focuses on the identification and quantitation of 
fragment ions that are generated from multiple peptides contained in the same 
selection window of several to tens of m/z, that is, the fragmentation spectra of all 
the peptides are acquired in each cycle time without any preselection of the precur-
sor ions [73].
The mass spectrometers are compounded basically into a sample inlet, an ion 
source, a mass analyzer and a detector [74, 75]. Although MS appeared more than a 
century ago, its application to protein analysis began in the 1990s, because existing 
ion sources only allowed the ionization and analysis of inorganic molecules and 
small organic molecules and proteins are not easily transferred to the gas phase 
and ionized by the size [76, 77]. Advancement of mass spectrometry technology 
occurred with the new instrumentation ionizer, matrix-assisted laser desorption/
ionization (MALDI) and electrospray ionization (ESI) [78–80]. The development 
of the mass analyzer applied to analyze intact proteins contributed to the mass 
spectrometry identification of the proteoforms. Mass analyzers with a high level 
of resolving power and sensitivity as time-of-flight (TOF), Orbitrap, Fourier 
Transform Ion Cyclotron Resonance (FT-ICR), or the combination of multiple mass 
analyzers in series, created a powerful tool for top-down MS characterization of 
proteoforms [78, 81, 82]. Most top-down proteomics (TDP) studies have used some 
form of tandem-MS fragmentation techniques, for intact proteins sequencing with 
greatly resolving power and high mass accuracy as: collisionally activated dissocia-
tion (CAD), collision-induced dissociation (CID), electron transfer dissociation 
(ETD), electron-capture dissociation (ECD), higher-energy collisional dissociation 
(HCD), infrared multiphoton dissociation (IRMPD) and ultraviolet photodissocia-
tion (UVPD). These examples of fragmentation strategies can provide additional 
information on the amino acid sequence and PTMs for identification of proteo-
forms [74, 75, 79, 83]. The mass spectrometer sample introduction can be through 
the traditional RPLC-MS, by CZE-MS or embedded in a matrix on a target plate 
[74, 84]. Mass spectrometers that use different types of analyzers for the first and 
second stages of mass analysis (hybrid MS instruments) are employed to maximize 
proteoform characterization top-down MS-based. Still, software tools for the 
identification and quantification of proteoforms need to be continuously developed 
to keep up with a demand to quickly and automatically analyze the data generated. 
Many a comprehensive proteoform software tools for proteoform identifica-
tion and construction of proteoform families are freely available: MASH Suite, 
MetaMorpheus, MSPathFinder, Proteoform Suite, TDPortal, TopMG and TopPIC 
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[13, 20] that can be implemented into current top-down workflows consecutive at 
complete and accurate databases.
A common material used is either surface-modified silica or polymeric particles 
coated with short aliphatic groups n-alkyls (propyl, butyl, hexyl, or octyl chains), 
phenyl and others [61, 85]. HIC separation methods have been evaluated and 
optimized as complementary selectivity to RPLC, which offer efficient separation 
for highly orthogonal HIC-RPLC for top-down proteomics [14, 27]. 
5. Clinical applications for proteoform identification
Several studies are carried out aiming to find markers for pathophysiology 
process of Alzheimer’s disease (AD), cancer [86], type 2 diabetes, and chronic 
alcohol abuse, among other diseases. The identification of proteoforms associated 
with different diseases will undoubtedly be an essential dividing mark for early 
diagnosis, prevention and treatment. Some examples for proteoform identification 
applications as apolipoproteins proteoforms, B-type natriuretic peptide (BNP), 
disorders of glycosylation, detection of structural changes in transthyretin, hemo-
globin proteoforms, cystatin C-truncated proteoforms, C-reactive protein, vitamin 
D-binding protein, transferrin and immunoglobulin G (NISTmAb) were discussed 
[86, 87]. In the last 30 years, since the MALDI and ESI approaches were developed, 
only about a dozen of mass spectrometry protein identification tests have been 
described. Here, we present studies involving Alzheimer’s disease and alterations in 
the levels of apolipoproteins associated with lipid metabolism.
5.1 Alzheimer’s disease
In the diagnosis of Alzheimer’s disease (AD), quantification of total Tau protein 
(T-tau), threonine-phosphorylated Tau181 form (P-Tau181), and the 42 amino 
acid peptide, alpha-amyloid isoform (Aβ) are well established as markers present 
in cerebrospinal fluid (CSF). However, there is a constant need for new diagnostic 
markers to identify the disease at a very early stage [87]. A review about the role of 
proteoforms in the pathophysiology process of Alzheimer’s disease was described 
in [88]. The mass spectrometry performance of three canonical proteins, clusterin, 
secretogranin-2, or chromogranin A, was presented. Variations on the levels of Apo 
A-1, a protein with antioxidant and anti-inflammatory properties, in the serum 
or in CSF, are also indicated as a potential marker for AD diagnosis and progres-
sion. Apo A-1 exhibits [86] and inhibits the aggregation and neurotoxicity of an 
amyloid-β peptide in AD [89]. The possible association between apolipoproteins 
increased Apo A-1 levels that were correlated with decreasing risk of dementia [87], 
raising the possibility of a novel role of Apo A-1 in protection against neurological 
disorders [87, 89].
5.2 Apolipoprotein and lipid metabolism
Possible correlations between apolipoprotein levels (Apo C-III, Apo C-I and 
Apo C-II) with dyslipidemia and cardiovascular disease were presented in [86]. 
Apolipoproteins function as the structural components of lipoprotein particles, 
cofactors for enzymes and ligands for cell-surface receptors. Apolipoproteins 
exhibit proteoforms associated with nucleotide polymorphisms (SNPs) and post-
translational modifications such as glycosylation, oxidation and sequence trunked 
[86]. The human apo Cs are protein constituents of chylomicrons, VLDL and 
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HDL. The protein APO C-III has 79 amino acids and can be glycosylated in the 
residue of Threonine 48. Initially, four APO C-III isoforms were identified by mass 
spectrometry and later 12 proteoforms. These proteoforms differ by absence of 
glycosylation (APO C-III Oa), glycosylation (APO C-III Ob), addition of one or two 
sialic acid residues (APO C-III 1, APO C-III 2) or addition of fucose at glycosylation 
sites. There are also truncated proteoforms due to amino acid substitution. Increases 
in APO C-III2 levels are associated with a reduction in TG and LDL levels, and 
perhaps this is a possible mechanism for dyslipidemia processes and reduced risk of 
cardiovascular disease (CVD) [86].
5.3 Cancer disease
The identification of novel biomarkers for early clinical-stage cancer detection, 
targeted molecular therapies, disease monitoring and drug development could 
impact on the future care of cancer patients. A systematic study of cancer samples 
using omics technologies, oncoproteomics, is in progress. He et al. summarize the 
advantages and limitations of the critical technologies used in (onco)proteogenom-
ics [90]. In other studies, Zhan et al. [91]compared MALDI-MS, LC-Q-TOF MS 
and LC-Orbitrap Velos MS for the identification of proteins within one spot. They 
described the importance of the development of stable isotope labeling coupled 
with 2DE-LC/MS in a large-scale study of human proteoforms. This powerful 
technique platform identified in Blue-stained 2DE spots at least 42 and 63 proteins/
spot in an analysis of a human glioblastoma proteome and a human pituitary 
adenoma proteome, respectively. A critical study to detect new proteomic markers 
of medullary thyroid carcinoma, combining MALDI-MSI and nLC-ESI-MS/MS 
were developed by [92]. They identified proteins as moesin, veriscan and lumican 
and intratumoural amyloid components, including calcitonin, apolipoprotein 
E, apolipoprotein IV and vitronectin with a potential role in medullary thyroid 
carcinoma pathogenesis [92].
6. Conclusion
In conclusion, the proteoform identification using a proteomic approach can 
be an advance in diagnostic routines and development of precision/personalized 
medicine. Efforts should be concentrated on clinical studies and then on, and one 
aspect that precludes is the cost and complexity of these tests. Therefore, studies to 
simplify sample preparation steps and MS platforms need to be performed to reduce 
cost per test.
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